Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   

The Angels Initiative

Stroke prevention

  Malignant Lymphoma

  Free Subscription

Articles published in J Immunol

Retrieve available abstracts of 7 articles:
HTML format

Single Articles

    February 2023
  1. ABBOUD G, Choi SC, Zhang X, Park YP, et al
    Glucose Requirement of Antigen-Specific Autoreactive B Cells and CD4+ T Cells.
    J Immunol. 2023;210:377-388.
    PubMed     Abstract available

    October 2022
  2. DOGAN M, Karhan E, Kozhaya L, Placek L, et al
    Engineering Human MAIT Cells with Chimeric Antigen Receptors for Cancer Immunotherapy.
    J Immunol. 2022;209:1523-1531.
    PubMed     Abstract available

    June 2022
  3. JIA X, Bene J, Balazs N, Szabo K, et al
    Age-Associated B Cell Features of the Murine High-Grade B Cell Lymphoma Bc.DLFL1 and Its Extranodal Expansion in Abdominal Adipose Tissues.
    J Immunol. 2022;208:2866-2876.
    PubMed     Abstract available

    January 2022
  4. TARSALAINEN A, Maman Y, Meng FL, Kylaniemi MK, et al
    Ig Enhancers Increase RNA Polymerase II Stalling at Somatic Hypermutation Target Sequences.
    J Immunol. 2022;208:143-154.
    PubMed     Abstract available

    August 2021
  5. DUBOIS S, Waldmann TA, Muller JR
    Effective Cytotoxicity of Dendritic Cells against Established T Cell Lymphomas in Mice.
    J Immunol. 2021;207:1194-1199.
    PubMed     Abstract available

    April 2021
  6. JIANG C, Zhao ML, Ramos L, Dobaczewska K, et al
    The Role of IgM Antibodies in T Cell Lymphoma Protection in a Novel Model Resembling Anaplastic Large Cell Lymphoma.
    J Immunol. 2021 Apr 21. pii: jimmunol.2001279. doi: 10.4049/jimmunol.2001279.
    PubMed     Abstract available

    March 2021
  7. MILANOVIC M, Shao Z, Estes VM, Wang XS, et al
    FATC Domain Deletion Compromises ATM Protein Stability, Blocks Lymphocyte Development, and Promotes Lymphomagenesis.
    J Immunol. 2021;206:1228-1239.
    PubMed     Abstract available

Thank you for your interest in scientific medicine.

AMEDEO Malignant Lymphoma is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.